Altria Group (MO) stands out as the highest-yielding Dividend King with a 6.4% forward dividend yield and 56 consecutive years of dividend increases. The tobacco giant, known for Marlboro cigarettes, recently received FDA approval for six on! PLUS nicotine pouch products under a streamlined pilot program. This regulatory green light positions Altria to expand beyond traditional cigarettes into next-generation products.

Despite declining cigarette volumes, Altria's financial performance remains solid with $5.8 billion in quarterly sales and $2.4 billion in net income. The company's dividend payout ratio sits at 76%, which while not alarming, warrants monitoring alongside earnings stability and debt levels. Wall Street analysts have given Altria a consensus Moderate Buy rating with a high price target of $72, suggesting approximately 6% upside from current levels around $68.

Altria's ability to navigate industry evolution while maintaining its dividend streak demonstrates resilience through market cycles. The FDA's recent authorization of nicotine pouches could accelerate growth in this segment, though regulatory risks remain. With shares up 53% over five years compared to a flat S&P 500, Altria offers income investors both yield and potential capital appreciation in an evolving tobacco landscape.